Skip to main content

Academic Research

NIH Awards $50.3 Million for “Multi-Omics” Research on Human Health and Disease

The National Institutes of Health is establishing the Multi-Omics for Health and Disease Consortium, with approximately $11 million awarded in the consortium’s first year of funding. The new consortium aims to advance the generation and analysis of “multi-omic” data for human health research.

September 14, 2023

Data Science and Medicine Converge to Bring Artificial Intelligence to the Clinic

As data science and medicine come together, artificial intelligence (AI) is opening new possibilities in nearly every medical specialty. At Brigham and Women’s Hospital, a large academic medical center within an even larger medical ecosystem, initiatives underway reveal how close we are to adding AI to the physician’s toolkit to improve patient care.

September 7, 2023

Photo 121466642 © Wrightstudio | Dreamstime.com

Mount Sinai Announces Partnership With the Brazilian Clinical Research Institute to Advance Cardiovascular Disease Research and Medical Education

The Icahn School of Medicine at Mount Sinai announced that it has signed a memorandum of understanding with the Brazilian Clinical Research Institute (BCRI) to focus on advancing cardiovascular disease research, innovation, and medical education.

September 7, 2023

Photo 76607355 | Cardiovascular Disease © Rawpixelimages | Dreamstime.com

Radical New Approach to Managing Type 2 Diabetes Receives $3.5 Million

The National Institutes of Health has provided $3.5 million for a large-scale clinical trial testing a radical new approach to managing type 2 diabetes that, in an earlier study, put almost 70% of participants in remission without weight loss or medication.

$19 Million from NIH Establishes Maternal Health Implementation Science Hub at Penn Medicine

Penn Medicine will serve a critical role in driving research to reduce pregnancy-related complications and deaths and promote maternal health equity through a new National Institutes of Health (NIH) grant. The $19 million, seven-year grant funds the creation of an implementation science hub as part of the NIH’s new Maternal Health Research of Centers of Excellence initiative.

ChatGPT Shows Limited Ability to Recommend Guidelines-Based Cancer Treatments

For many patients, the internet serves as a powerful tool for self-education on medical topics. With ChatGPT now at patients’ fingertips, researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, assessed how consistently the artificial intelligence chatbot provides recommendations for cancer treatment that align with National Comprehensive Cancer Network (NCCN) guidelines. Their findings, published in JAMA Oncology, show that in approximately one-third of cases, ChatGPT 3.5 provided an inappropriate (“non-concordant”) recommendation, highlighting the need for awareness of the technology’s limitations.

UH Disinfection Research Team Able to Tap Department of Homeland Security Startup Resources Following Successful Accelerator

A University Hospitals research team, which recently presented its unique, high-level disinfection system at the Homeland Security Startup Studio’s (HSSS) Converge event, received news that it is moving to an ”alumni” phase of the program that encourages company formation and commercialization of technology.

AI Model Developed by Brigham Researchers Could Help Screen for Heart Defect

The AI model was more efficient at detecting signatures of atrial septal defect (ASD) in electrocardiograms (ECG) than traditional methods.

Coronary Artery Disease Discovery Offers Answers About No. 1 Killer

UVA Health researchers probing the causes of coronary artery disease – the nation’s No. 1 killer – have identified critical biological processes that can go wrong inside the linings of our blood vessels and contribute to the dangerous plaque buildup responsible for the disease.

Duke University Health System Launches OneDukeGen, a New Precision Medicine Study

The Duke University Health System and School of Medicine are launching OneDukeGen, a precision medicine study that will advance healthcare through cutting-edge research and collaboration. In a partnership with nference, OneDukeGen will embark on a journey to unravel the intricate connections between genetics, health, and disease.

UVA Cancer Center Seeks Innovative Ideas to Improve Care, Reduce Health Disparities

To reduce cancer’s impact and enhance health equity, University of Virginia Cancer Center will award as many as five grants of up to $10,000 to support innovative, community-based projects that have the potential to improve cancer care and prevention.

George Washington University Launches Medicaid Workforce Tracker

To improve access to high-quality Medicaid services, experts must first locate the gaps in healthcare providers available to patients who rely on this health insurance. Researchers at the George Washington University launched an interactive online tracking system that identifies states and counties in the United States that suffer from a shortage of primary care providers who see Medicaid patients.

Learning the Language of Cells to Beat Cancer

Human cells are constantly communicating, and some cells, particularly in cancer, are master manipulators, using these communications channels to persuade innocent bystander cells to collude and participate in tumor growth. If science can better understand how these good cells are “flipped,” or induced to go rogue, it would open the door for new treatment options that could save many lives.

Study Identifies Characteristics Associated with High Fidelity During Patient Handoffs

Patient handoffs are a critical transition point. Evidence suggests standardized protocols during handoffs improve communication, teamwork, professionalism and patient outcomes. However, the factors underpinning adherence to standardized protocols are not well specified.

Researchers Develop AI Model to Better Predict Which Drugs May Cause Birth Defects

Data scientists at the Icahn School of Medicine at Mount Sinai in New York and colleagues have created an artificial intelligence model that may more accurately predict which existing medicines, not currently classified as harmful, may in fact lead to congenital disabilities.

Back to top